FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
5 letters match. Newest first.
-
DrugsSourav K. Mishra, M.D. / All India Institute of Medical Sciences
FDA warned clinical investigator Dr. Sourav K. Mishra at AIIMS Bhubaneswar over a doxorubicin liposome bioequivalence study that broke protocol and consent rules.
High risk -
DrugsMukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
FDA warned clinical investigator Dr. Mukesh Chandre over informed consent failures in a doxorubicin liposome bioequivalence study.
High risk -
DrugsMelanie M. Hoppers, M.D./Physicians Quality Care
FDA warns Dr. Melanie Hoppers over enrolling ineligible patients in a baloxavir marboxil influenza trial.
High risk -
DrugsRobert J. Hayashi, M.D./Washington University School of Medicine, Department of Pediatrics
FDA warned Dr. Robert J. Hayashi over protocol deviations in pediatric drug trials that exposed a child to unnecessary study drug and invasive procedures.
High risk -
DrugsAdarsh Daswani, M.D.
Clinical investigator Adarsh Daswani, M.D. failed to follow protocol dosing and oversight for an investigational drug study.
High risk